Altria Group reported Q1 2026 adjusted earnings per share (EPS) of $1.32, exceeding Wall Street consensus by 7 cents, according to an SEC 8-K filing dated April 30, 2026.
Q1 2026 Results at a Glance
Altria's first-quarter net revenues reached $5.4 billion (approximately $5.4 billion), a 3.2% increase versus the prior-year period, driven primarily by higher cigarette segment sales. Net revenues excluding excise taxes climbed 5.3% to $4.8 billion. Adjusted EPS rose 7.3% to $1.32 from $1.23 in the year-ago quarter. Diluted GAAP EPS surged to $1.30 from $0.63, a gain exceeding 100%, reflecting a favorable year-over-year comparison after the prior year included a non-cash goodwill impairment charge of $873 million related to the e-vapor segment.
- Net revenues: $5.4 billion, +3.2% YoY
- Net revenues excluding excise taxes: $4.8 billion, +5.3% YoY
- Adjusted EPS: $1.32, beats consensus of $1.25 by 7 cents
- GAAP diluted EPS: $1.30 versus $0.63 YoY, +100%+ growth
- Q1 share repurchases: $280 million, 4.5 million shares at average price of $62.33
- Q1 dividend payments: $1.8 billion
2026 Full-Year Outlook
Altria reaffirmed its 2026 full-year adjusted EPS guidance of $5.56–$5.72, representing 2.5–5.5% growth versus the 2025 baseline of $5.42. CEO Billy Gifford noted that strong first-quarter results suggest more balanced EPS growth between the first and second halves of the year. The company's outlook factors in moderating e-vapor market growth and macroeconomic uncertainty. NJOY ACE is not expected to return to the U.S. market during 2026, amid ongoing regulatory actions.
Market Reception
Reuters reported that Altria's quarterly earnings exceeded Wall Street expectations. StreetInsider noted the adjusted EPS beat of 7 cents. GuruFocus highlighted valuation discussions following the earnings beat. Specific post-announcement stock price movement figures were not disclosed in the filing or available wire reports.
Segment Performance
- Smokable products (cigarettes): Net revenue growth drove overall earnings gains, as noted in the filing. Segment-specific revenue figures not disclosed.
- Oral tobacco: The on! brand performed competitively in a challenging market. on! PLUS was rolled out nationally. Segment-specific revenue figures not disclosed.
- E-vapor (NJOY): NJOY ACE faces a U.S. International Trade Commission (ITC) import ban and sales suspension order, preventing 2026 re-entry. Segment-specific revenue figures not disclosed.
This article was auto-generated from the SEC 8-K filing and third-party news reports for rapid dissemination of key data following the announcement. Investors are advised to review the official company filing prior to making trading decisions.
